Akebia Therapeutics, Inc. (FRA:AX9)
Germany
· Delayed Price · Currency is EUR 1.339
+0.043 (3.32%)
At close: Dec 5, 2025
Akebia Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -15.91 | -69.41 | -51.93 | -94.23 | -282.02 | -384.84 | Upgrade
|
| Depreciation & Amortization | 14.49 | 41.7 | 41.85 | 37.7 | 37.97 | 34.69 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.17 | - | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 0.78 | 8.77 | - | 114.43 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | -0.02 | -0.05 | Upgrade
|
| Stock-Based Compensation | 9.78 | 7.78 | 9.32 | 17.85 | 22.74 | 24.46 | Upgrade
|
| Provision & Write-off of Bad Debts | 2.26 | 0.88 | - | - | - | - | Upgrade
|
| Other Operating Activities | 30.57 | 18.07 | -2.68 | -41.8 | 73.98 | 113.78 | Upgrade
|
| Change in Accounts Receivable | -36.31 | 4.05 | 0.99 | 11.3 | -24.03 | 11.67 | Upgrade
|
| Change in Inventory | -14.2 | -28.4 | -2.54 | 19.09 | -24.95 | 6.16 | Upgrade
|
| Change in Accounts Payable | -4.94 | -1.36 | -5.24 | 1.5 | -11.74 | 3.68 | Upgrade
|
| Change in Unearned Revenue | 3.88 | - | -3.74 | 4.65 | 1.82 | -32.39 | Upgrade
|
| Change in Other Net Operating Assets | 42.95 | -13.96 | -10.2 | -37.98 | -46.72 | -1.97 | Upgrade
|
| Operating Cash Flow | 32.4 | -40.66 | -23.38 | -73.15 | -252.97 | -110.39 | Upgrade
|
| Capital Expenditures | -0.22 | -0.03 | - | -0.11 | -0.06 | -0.32 | Upgrade
|
| Investment in Securities | - | - | - | - | 40 | -39.69 | Upgrade
|
| Investing Cash Flow | -0.05 | -0.03 | - | -0.11 | 39.94 | -40 | Upgrade
|
| Long-Term Debt Issued | - | 45 | - | - | - | 19.98 | Upgrade
|
| Long-Term Debt Repaid | - | -37.1 | -32 | -33 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 9.54 | 7.9 | -32 | -33 | - | 19.98 | Upgrade
|
| Issuance of Common Stock | 90.62 | 43.03 | 6.79 | 7.6 | 88.95 | 211.75 | Upgrade
|
| Other Financing Activities | -0.06 | -1.27 | - | 40 | 44.78 | - | Upgrade
|
| Financing Cash Flow | 100.1 | 49.66 | -25.21 | 14.6 | 133.73 | 231.72 | Upgrade
|
| Net Cash Flow | 132.45 | 8.97 | -48.59 | -58.67 | -79.29 | 81.33 | Upgrade
|
| Free Cash Flow | 32.17 | -40.69 | -23.38 | -73.27 | -253.02 | -110.71 | Upgrade
|
| Free Cash Flow Margin | 14.29% | -25.40% | -12.02% | -25.05% | -119.55% | -37.57% | Upgrade
|
| Free Cash Flow Per Share | 0.13 | -0.19 | -0.13 | -0.40 | -1.52 | -0.80 | Upgrade
|
| Cash Interest Paid | 5.04 | 5.04 | 6.06 | 6.76 | 9.63 | 7.84 | Upgrade
|
| Levered Free Cash Flow | 50.71 | 17.83 | 22.11 | -15.3 | -136.04 | -17.99 | Upgrade
|
| Unlevered Free Cash Flow | 67.1 | 29.2 | 25.88 | -5.5 | -123.53 | -12.42 | Upgrade
|
| Change in Working Capital | -8.63 | -39.68 | -20.73 | -1.44 | -105.61 | -12.86 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.